SY1 (SY1) News
Follow SY1 (SY1) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 14 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Symrise Shares Plunge as Company Flags Slower Growth and Margin Pressure
Symrise shares fell as much as 12% on Wednesday after the German flavor and fragrance maker flagged slower year-end growth and margin pressure. It maintained full-year guidance while specifying its forecast to account fo
EQUITY | Oct 28, 2026, 09:33 AM UTC
M
Symrise Reports Quarterly Sales After Shares Fall
Symrise reported sales of 1.31 billion euros for the quarter ended September. Shares fell after the results were described as disappointing ahead of a softer fourth quarter.
EARNINGS | Oct 28, 2026, 08:45 AM UTC
M
Symrise Reports 5.3% Q3 Organic Sales Growth, Reaffirms 2026 Outlook
Symrise reported third-quarter group sales of 1.31 billion euros, compared with 1.22 billion euros a year earlier. Organic sales growth was 5.3%.
EARNINGS | Oct 28, 2026, 08:11 AM UTC
M
Symrise Forecasts Slower Q4 Growth, Flags Margin Pressure
Symrise expects growth to moderate sequentially from the third quarter as tougher comparables weigh, while reinvestment spending is expected to pressure its annual profit margin.
EARNINGS | Oct 28, 2026, 07:20 AM UTC
M
Symrise Reports Q3 Group Sales of €1.31 Billion
EARNINGS | Oct 28, 2026, 06:35 AM UTC
L
Brenntag Enters Distribution Agreement With Symrise In Brazil
Brenntag SE XETR:BNR
NEWS | Sep 28, 2026, 01:07 PM UTC
M
Symrise flags profit decline, missed growth targets, and EU probes
Symrise reported profit declines after end-2025 write-downs, missed organic growth and new product targets, and is selling its U.S. terpene unit AmeriTerpenes to Mutares with supply deals intact. EU antitrust probes cont
REGULATION | Sep 07, 2026, 05:15 AM UTC
L
Symrise to sell AmeriTerpenes business to Mutares
Symrise said it will divest AmeriTerpenes, its American terpene-ingredients maker, to private-equity firm Mutares for an undisclosed sum.
EQUITY | Sep 01, 2026, 09:44 AM UTC
M
Symrise agrees sale of U.S. terpene ingredients business to Mutares
Symrise has inked a deal to sell its American terpene-ingredients producer to private-equity firm Mutares for an undisclosed sum as it focuses on growing other parts of the business.
EQUITY | Sep 01, 2026, 08:58 AM UTC
L
Jefferies raises Symrise target to EUR110 from EUR80
Jefferies raised its Symrise price target to EUR110.00 from EUR80.00.
EQUITY | Sep 01, 2026, 07:37 AM UTC
L
Jefferies upgrades Symrise to Buy
Jefferies upgraded Symrise from Hold to Buy, according to TradingView News.
EQUITY | Sep 01, 2026, 07:37 AM UTC
L
Symrise agrees to divest terpene ingredients unit to Mutares SE
Symrise has agreed to divest its terpene ingredients business to Mutares SE for an undisclosed sum.
EQUITY | Sep 01, 2026, 06:18 AM UTC
M
Symrise signs agreement to divest terpene ingredients business to Mutares
Symrise has signed an agreement to divest its terpene ingredients business to Mutares.
EQUITY | Sep 01, 2026, 05:40 AM UTC
L
DAX closes 0.41% lower as Adidas, Rheinmetall lead losses
The DAX index fell 108 points, or 0.41%, on Thursday to close at 25,983 points, with Adidas, Rheinmetall and MTU Aero Engines among the biggest decliners.
EQUITY | Aug 20, 2026, 04:11 PM UTC